FDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics
#FDA #Marty Makary #Trump #Psychedelic Drugs #Mental Health #Executive Order #Clinical Trials
📌 Key Takeaways
- WHO: Dr. Marty Makary, FDA Commissioner
- WHAT: Expansion of research into psychedelic drugs for mental health treatment.
- WHERE: The discussion was featured on CBS News.
- WHEN: The context is the recent executive order signed by President Trump.
- WHY: To discuss the expansion of research into psychedelics for mental health treatment.
📖 Full Retelling
The Food and Drug Administration (FDA) Commissioner, Dr. Marty Makary, joined CBS News to discuss the recent executive order issued by President Trump, which expands research into psychedelic drugs for mental health treatment.
🏷️ Themes
FDA Policy, Psychedelic Research, Mental Health Treatment, Executive Order, Pharmaceutical Regulation
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
President Trump has signed an executive order to expand research into psychedelic drugs for mental health treatment. Dr. Marty Makary, commissioner of the Food and Drug Administration, joins CBS News to discuss.
Read full article at source